Stock listing

ALVO Stock Price, News, Filings & Events — Alvotech

Selected listing: ALVO · OMXICE · ISK · IS

This page tracks Alvotech's ALVO:OMXICE listing on OMXICE in ISK for IS, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALVO:OMXICE. ALVO:OMXICE is the stock-level entry point for investors researching Alvotech, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Alvotech is a public company listed under the ticker ALVO, operating in the American market. The company has a market capitalization of approximately $1.19 billion. Alvotech focuses on developing and manufacturing biosimilars to improve patient access to biologic therapies.

ALVO:OMXICEISKISUpdated August 28, 2026
Alvotech logo
Ticker
ALVO:OMXICE
Asset type
Stock
Market cap
$1.93B
Sector
Health Technology
Industry
Biotechnology
Exchange
OMXICE
Currency
ISK

Alvotech ALVO:OMXICE stock context

This page tracks Alvotech's ALVO:OMXICE listing on OMXICE in ISK for IS, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALVO:OMXICE. ALVO:OMXICE is the stock-level entry point for investors researching Alvotech, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Alvotech is a public company listed under the ticker ALVO, operating in the American market. The company has a market capitalization of approximately $1.19 billion. Alvotech focuses on developing and manufacturing biosimilars to improve patient access to biologic therapies.

Latest news from Alvotech

All Alvotech news →

Alvotech earnings calls

Research Alvotech

Alternate listings